number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide GLP-1 prescription trends through June Major Increase in Prescribed Drugs

GLP-1 receptor agonists such as semaglutide (Wegovy and Ozempic) and trizepatide (Mounjaro) mimic the bodys natural hormones, which regulate appetite and insulin secretion

Diabetic retinopathy is the leading reason for visual loss in Western countries

The company also announced a new $15 billion share repurchase program which signals the companys shift in priorities toward shareholder enrichment

Bonus This course is packed with actionable insights you can use immediately to help patients see real, transformational results

Not only can it reduce the risk of several dangerous health conditions, but it also helps us maintain a regular toilet routine

Step 8: Monthly refill surveys for ongoing care